Pharmaceutical Business review

Paladin takes over Tempra from Bristol Myers Squibb

Paladin’s product line includes both over-the-counter (OTC) and prescription drugs such as Zincofax for diaper rash, Anbesol for teething, Cerumol for ear wax removal, Twinject for anaphylaxis, and Kaeopectate for diarrhea.

Paladin president and CEO Jonathan Ross Goodman said Tempra has strong brand equity in Canada among parents and physicians.

"Building on our existing distribution activities, Tempra will prove synergistic and provide additional critical mass and strategic options for further developing our Canadian OTC presence," Goodman said.